# Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer

> **NCT00178373** · PHASE2 · COMPLETED · sponsor: **University of Rochester** · enrollment: 96 (estimated)

## Conditions studied

- Cancer
- Fatigue
- Chemotherapy

## Interventions

- **DRUG:** Modafinil
- **DRUG:** sugar pill

## Key facts

- **NCT ID:** NCT00178373
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-12
- **Final completion:** 2006-03
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2015-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00178373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00178373, "Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00178373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*